Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Other Accumulated Expenses: 2009-2025

Historic Other Accumulated Expenses for Argan (AGX) over the last 5 years, with Oct 2025 value amounting to $7.5 million.

  • Argan's Other Accumulated Expenses fell 40.81% to $7.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.5 million, marking a year-over-year decrease of 40.81%. This contributed to the annual value of $19.2 million for FY2025, which is 122.06% up from last year.
  • Per Argan's latest filing, its Other Accumulated Expenses stood at $7.5 million for Q4 2025, which was down 59.19% from $18.4 million recorded in Q3 2025.
  • Argan's 5-year Other Accumulated Expenses high stood at $25.6 million for Q2 2025, and its period low was $7.5 million during Q4 2025.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $11.8 million (2023), whereas its average is $13.1 million.
  • Over the last 5 years, Argan's Other Accumulated Expenses had its largest YoY gain of 122.06% in 2025, and its largest YoY loss of 40.81% in 2025.
  • Argan's Other Accumulated Expenses (Quarterly) stood at $13.4 million in 2022, then decreased by 6.31% to $11.1 million in 2023, then increased by 14.39% to $12.7 million in 2024, then plummeted by 40.81% to $7.5 million in 2025.
  • Its Other Accumulated Expenses was $7.5 million in Q4 2025, compared to $18.4 million in Q3 2025 and $25.6 million in Q2 2025.